S100P in pancreatic adenocarcinoma showed a similar trend, with 24.02 and 20.3-fold changes in Iacobuzio-Donahue’s and Logsdon’s datasets, respectively. This evidence concerns the gene S100P and pancreatic adenocarcinoma.